Parents, teachers, and pediatricians have been waiting with bated breath to learn when children in the United States will be able to receive the COVID-19 vaccination.
The US has approved child-size doses of the Pfizer vaccine, making it available to the estimated 28 million youngsters aged 5 to 11 in the US. Here’s all you need to know about the COVID-19 vaccine for kids.
What Should Children Know About The Covid Vaccine?
When will the photos be released and where will they be available?
The supplies should start arriving by the end of the week, around the same time as children’s immunization appointments are expected to open up.
Over the weekend, White House COVID-19 response coordinator Jeffrey Zients told NPR, “We urge parents to get ready and establish a plan, and the program will be fully up and running the week of November 8.”
The vaccine will be accessible at more than 25,000 pediatricians’ and doctors’ offices, hospitals, pharmacies, and other facilities around the country, according to the Biden administration, which asked these clinics and states to begin placing orders last week. According to the White House, enough shots have been ordered to vaccinate all 5- to 11-year-olds in the country.
What do we know so far about Pfizer’s COVID vaccination for kids?
Last Monday, the FDA granted Pfizer’s vaccination for children aged 5 to 11 years old an emergency-use authorization. The vaccination was unanimously recommended by the Centers for Disease Control and Prevention’s advisors on Tuesday, and CDC Director Rochelle Walensky also signed off.
Children will receive two doses three weeks apart, just as teens and adults, but the Pfizer vaccination dosages are just a third of the adult doses. The kiddie vaccination, according to NPR, varies from the present formulation given to teens and adults in that it may be kept in the refrigerator for up to ten weeks.
Is the COVID vaccine from Pfizer safe for children?
Yes. On the basis of clinical-trial data suggesting that the Pfizer injection is roughly 91 percent effective at avoiding symptomatic illness in 5- to 11-year-olds, the FDA advisory council voted in support of approval last week.
The results of the 2,268-person experiment suggest that it is safe: Despite the fact that mRNA-based vaccines have been related to a very tiny risk of myocarditis (heart muscle inflammation), there were no reports of the ailment in the children who took part in the study.
Children’s doses were likewise shown to be safe, with transitory responses to the vaccine similar to or less than those experienced by teenagers, such as aching arms, fever, or pains.
When will other COVID vaccines for children become available?
For the time being, the Moderna and Johnson & Johnson shots are only available to persons aged 18 and up. Pfizer and Moderna are both investigating vaccines for newborns and preschoolers, and the Moderna mRNA vaccine is still being tested in young children and teens.
Meanwhile, Johnson & Johnson is lagging behind: it plans to start vaccine trials for its injection for young children in the near future but has yet to start a trial for children aged 16 and younger.
These vaccines will still have to go through the same regulatory process as the Pfizer vaccine, which is already in the works.